IDEXX Reaches Agreement with Bureau of Competition

Earlier this month, IDEXX Laboratories, Inc. (NASDAQ, IDXX) announced it has signed an agreement with the Federal Trade Commission, Bureau of Competition to resolve the investigation into whether the Company engaged in unfair methods of competition.

Under the Consent Agreement, IDEXX cannot have exclusive distribution agreements with all three of MWI Veterinary Supply, Inc. ("MWI"), Butler Schein Animal Health, and Webster Veterinary. IDEXX may maintain exclusive distribution agreements with two of these three distributors. IDEXX's non-exclusive agreement with MWI, effective January 1, 2013, brings the Company into compliance with the terms of the Consent Agreement. 

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 5,000 people and offers products to customers in over 100 countries.

Read the whole story

Idexx Sees Organic Growth in First Quarter

Second Quarter to Begin Launching New Products 

Although the economic climate remains challenging for businesses, Idexx Laboratories continues to bring innovative products and services to their customers. This has resulted in a 10 per cent increase in revenues during the first quarter of 2012. 

To continue their success, Idexx has proposed to launch new products to expand the diagnostic capability of veterinarians.

To read the official Press Release, click here.